Privia Health Group, Inc. (NASDAQ:PRVA) Receives $24.79 Consensus Target Price from Brokerages

Privia Health Group, Inc. (NASDAQ:PRVA - Get Free Report) has been assigned an average rating of "Buy" from the fifteen analysts that are presently covering the stock, MarketBeat.com reports. Two research analysts have rated the stock with a hold rating, eleven have assigned a buy rating and two have issued a strong buy rating on the company. The average 12 month price objective among brokers that have issued ratings on the stock in the last year is $24.79.

Several analysts recently weighed in on PRVA shares. JPMorgan Chase & Co. lifted their price target on Privia Health Group from $27.00 to $28.00 and gave the stock an "overweight" rating in a report on Friday, November 29th. Truist Financial lifted their target price on Privia Health Group from $24.00 to $27.00 and gave the stock a "buy" rating in a report on Friday, November 8th. Robert W. Baird boosted their target price on shares of Privia Health Group from $23.00 to $24.00 and gave the company an "outperform" rating in a research report on Monday, August 26th. KeyCorp started coverage on shares of Privia Health Group in a research report on Friday, October 11th. They set an "overweight" rating and a $23.00 price target on the stock. Finally, Barclays boosted their price objective on shares of Privia Health Group from $19.00 to $21.00 and gave the company an "equal weight" rating in a report on Friday, November 8th.

Hedge Funds Weigh In On Privia Health Group

Institutional investors have recently modified their holdings of the business. Victory Capital Management Inc. grew its position in Privia Health Group by 402.9% in the third quarter. Victory Capital Management Inc. now owns 179,049 shares of the company's stock valued at $3,260,000 after acquiring an additional 143,446 shares during the last quarter. GAMMA Investing LLC boosted its stake in shares of Privia Health Group by 98.7% in the 3rd quarter. GAMMA Investing LLC now owns 1,701 shares of the company's stock valued at $31,000 after purchasing an additional 845 shares in the last quarter. Dynamic Technology Lab Private Ltd bought a new stake in shares of Privia Health Group during the 3rd quarter valued at approximately $1,206,000. Peregrine Capital Management LLC increased its position in Privia Health Group by 11.5% during the 2nd quarter. Peregrine Capital Management LLC now owns 314,190 shares of the company's stock worth $5,461,000 after purchasing an additional 32,311 shares in the last quarter. Finally, BlackBarn Capital Partners LP lifted its stake in Privia Health Group by 100.0% in the 2nd quarter. BlackBarn Capital Partners LP now owns 400,000 shares of the company's stock valued at $6,952,000 after purchasing an additional 200,000 shares during the last quarter. Institutional investors and hedge funds own 94.48% of the company's stock.

Privia Health Group Stock Performance

PRVA traded up $0.06 on Friday, reaching $20.96. The company had a trading volume of 390,841 shares, compared to its average volume of 838,768. The company's fifty day moving average is $19.96 and its 200 day moving average is $19.02. The stock has a market cap of $2.52 billion, a P/E ratio of 209.60, a P/E/G ratio of 5.49 and a beta of 0.83. Privia Health Group has a fifty-two week low of $15.92 and a fifty-two week high of $24.30.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.